Wieckiewicz Gniewko, Stokłosa Iga, Stokłosa Maciej, Gorczyca Piotr, Pudlo Robert
Department and Clinic of Psychiatry, Medical University of Silesia, Tarnowskie Góry, Poland.
Front Psychiatry. 2022 Mar 22;13:837946. doi: 10.3389/fpsyt.2022.837946. eCollection 2022.
Cannabis sativa, whose flowers are also known as marijuana or marihuana, is a recreational plant that contains many chemicals that are constantly being studied by scientists around the world. One of these substances is cannabidiol (CBD), which has gained widespread popularity on the internet as a cure for mental health problems, leading many people to use CBD to self-treat depression and anxiety. This article presents an exploratory cohort study ( = 90) of a group of people aged 16-69 using CBD to self-heal depression symptoms. The survey included basic sociodemographic questionnaire and validated Hospital Depression and Anxiety Scale. And was distributed the Internet. The results were statistically analyzed. High school degree was the most commonly held education (46%), large city was the most popular place of living (33%) and majority of the respondents have a full-time job (53%). Only 19% of the respondents consult their doctor or pharmacists about taking CBD. On the group of psychiatric patients, only 49% of respondents tell their psychiatrist about using the compound. Psychiatrists should be aware of CBD use in their patients during their daily practice, as CBD use can be found within people from all walks of life, and due to public interest, there is a need for education and research on the efficacy and safety of CBD use for mental disorders.
大麻,其花也被称为大麻或麻烟,是一种用于消遣的植物,含有许多化学物质,世界各地的科学家一直在对其进行研究。其中一种物质是大麻二酚(CBD),它在互联网上作为一种治疗心理健康问题的药物而广受欢迎,导致许多人使用CBD自我治疗抑郁症和焦虑症。本文介绍了一项探索性队列研究(n = 90),研究对象是一组年龄在16至69岁之间使用CBD自我治愈抑郁症状的人群。该调查包括基本的社会人口统计问卷和经过验证的医院抑郁与焦虑量表。并在互联网上进行了分发。对结果进行了统计分析。高中学历是最常见的学历(46%),大城市是最受欢迎的居住地点(33%),大多数受访者有全职工作(53%)。只有19%的受访者就服用CBD咨询过医生或药剂师。在精神科患者群体中,只有49%的受访者告知他们的精神科医生使用了该化合物。精神科医生在日常诊疗中应意识到患者使用CBD的情况,因为各行各业的人都可能使用CBD,并且由于公众的兴趣,有必要对CBD用于精神障碍的疗效和安全性进行教育和研究。